MasterMediTech Co.
Latest round
- Series A
Last raised
- Mar 2021
Total raised
- $7.1M
Investors
- 4
About MasterMediTech Co.
Based in Seoul, South Korea, and founded in 2019, MasterMeditech using chemical technology develops new drugs. As of 2023, the company is headed by its CEO Bongjin LEE. The company specialized in drug discovery using protein structure and medicinal chemistry technology.
Who invested in MasterMediTech Co.
4 investors across 1 round
See all investors in MasterMediTech Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 29, 2021
Amount
$7.1M
Investors
Questions about MasterMediTech Co.
Who invested in MasterMediTech Co.?
MasterMediTech Co. has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MasterMediTech Co. raised?
MasterMediTech Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MasterMediTech Co. last raise money?
MasterMediTech Co.'s most recent round on record is a Series A, in Mar 2021.
What does MasterMediTech Co. do?
Based in Seoul, South Korea, and founded in 2019, MasterMeditech using chemical technology develops new drugs.
Where is MasterMediTech Co. headquartered?
MasterMediTech Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like MasterMediTech Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at MasterMediTech Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like MasterMediTech Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.